VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 715 filers reported holding VANECK VECTORS ETF TR in Q4 2020. The put-call ratio across all filers is 1.18 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,124,838 | -6.6% | 41,800 | +4.5% | 0.00% | -33.3% |
| Q2 2023 | $1,204,400 | -12.4% | 40,000 | -5.9% | 0.00% | 0.0% |
| Q1 2023 | $1,374,875 | +35.1% | 42,500 | +19.7% | 0.00% | 0.0% |
| Q4 2022 | $1,017,430 | +36.0% | 35,500 | +14.5% | 0.00% | +50.0% |
| Q3 2022 | $748,000 | -40.0% | 31,000 | -31.9% | 0.00% | -33.3% |
| Q2 2022 | $1,246,000 | -61.3% | 45,500 | -45.8% | 0.00% | 0.0% |
| Q1 2022 | $3,222,000 | -53.4% | 84,000 | -61.1% | 0.00% | -80.0% |
| Q4 2021 | $6,918,000 | +738.5% | 216,000 | +671.4% | 0.02% | +650.0% |
| Q3 2021 | $825,000 | +85.4% | 28,000 | +113.7% | 0.00% | +100.0% |
| Q2 2021 | $445,000 | -9.9% | 13,100 | -13.8% | 0.00% | -50.0% |
| Q1 2021 | $494,000 | -93.9% | 15,200 | -93.3% | 0.00% | -93.3% |
| Q4 2020 | $8,126,000 | +757.2% | 225,600 | +832.2% | 0.03% | +500.0% |
| Q3 2020 | $948,000 | +6.8% | 24,200 | 0.0% | 0.01% | 0.0% |
| Q2 2020 | $888,000 | -37.4% | 24,200 | -60.7% | 0.01% | -54.5% |
| Q1 2020 | $1,418,000 | -81.3% | 61,548 | -76.3% | 0.01% | -76.6% |
| Q4 2019 | $7,591,000 | +628.5% | 259,241 | +564.6% | 0.05% | +571.4% |
| Q3 2019 | $1,042,000 | -49.6% | 39,010 | -51.8% | 0.01% | -50.0% |
| Q2 2019 | $2,067,000 | +25.8% | 80,880 | +10.3% | 0.01% | +16.7% |
| Q1 2019 | $1,643,000 | -37.9% | 73,317 | -41.6% | 0.01% | -50.0% |
| Q4 2018 | $2,647,000 | +138.5% | 125,500 | +109.4% | 0.02% | +200.0% |
| Q3 2018 | $1,110,000 | -56.7% | 59,920 | -47.9% | 0.01% | -77.1% |
| Q2 2018 | $2,566,000 | -40.9% | 115,015 | -41.8% | 0.04% | -38.6% |
| Q1 2018 | $4,341,000 | -49.7% | 197,490 | -46.8% | 0.06% | -50.9% |
| Q4 2017 | $8,632,000 | +2507.9% | 371,400 | +2479.2% | 0.12% | +1833.3% |
| Q3 2017 | $331,000 | -92.9% | 14,400 | -93.2% | 0.01% | -92.6% |
| Q2 2017 | $4,686,000 | -15.6% | 212,192 | -12.9% | 0.08% | -22.1% |
| Q1 2017 | $5,554,000 | +1776.4% | 243,500 | +2073.1% | 0.10% | +1633.3% |
| Q3 2016 | $296,000 | -77.2% | 11,205 | -76.1% | 0.01% | -82.4% |
| Q2 2016 | $1,301,000 | – | 46,938 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| New Harbor Financial Group, LLC | 1,221,955 | $36,011,000 | 14.81% |
| New Harbor Financial Group, LLC | 1,155,900 | $34,064,000 | 14.01% |
| Memorial Sloan Kettering Cancer Center | 738,500 | $21,764,000 | 13.56% |
| Hollow Brook Wealth Management LLC | 670,275 | $19,753,000 | 12.24% |
| Grand Central Investment Group | 293,243 | $8,642,000 | 11.46% |
| BW Gestao de Investimentos Ltda. | 940,800 | $27,725,000 | 8.44% |
| Slate Path Capital LP | 5,930,000 | $174,757,000 | 7.97% |
| Nokomis Capital, L.L.C. | 512,628 | $15,107,000 | 7.14% |
| Plaisance Capital LLC | 288,000 | $8,487,000 | 6.05% |
| Guild Investment Management, Inc. | 200,114 | $5,897,000 | 5.68% |